High-frequency homologous genetic recombination of an arterivirus, lactate dehydrogenase-elevating virus, in mice and evolution of neuropathogenic variants

Virology

Volumn 258, Issue 1, 1999, Pages 73-83

  Li, Kehan ^a   Chen, Zongyu ^a   Plagemann, Peter ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LACTATE DEHYDROGENASE;

ARTERIVIRUS; ARTICLE; EVOLUTION; GENETIC RECOMBINATION; LACTIC DEHYDROGENASE TOGAVIRUS; NEUROPATHOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS;

EID: 0033602710     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.9660     Document Type: Article

References (25)

1. Anderson G. W., Even C., Rowland R. R. R., Palmer G. A., Harty J. T., Plagemann P. G. W. C58 and AKR mice of all ages develop motor neuron disease after lactate dehydrogenase-elevating virus infection but only if antiviral immune responses are blocked by chemical or genetic means or as a result of old age. J. Neurovirol. 1:1995a;244-252.
2. Anderson G. W., Palmer G. A., Rowland R. R. R., Even C., Plagemann P. G. W. Lactate dehydrogenase-elevating virus entry into central nervous system and replication in anterior horn neurons. J. Gen. Virol. 76:1995b;581-592.
3. Baric R. S., Fu K., Schaad M. C., Stohlman S. A. Establishing a genetic recombination map for murine coronavirus strain A59 complementation groups. Virology. 177:1990;646-656.
4. Brinton-Darnell M., Plagemann P. G. W. Structure and chemical-physical characteristics of lactate dehydrogenase-elevating virus and its RNA. J. Virol. 16:1975;420-433.
5. Cavanagh D. Nidovirales:CoronaviridaeArteriviridae. Arch. Virol. 142/143:1997;629-633.
6. Chen Z., Kuo L., Rowland R. R. R., Even C., Faaberg K. S., Plagemann P. G. W. Sequence of 3′-end of genome and of 5′-end of ORF 1a of lactate dehydrogenase-elevating virus and common junction motifs between 5′-leader and bodies of seven subgenomic mRNAs. J. Gen. Virol. 74:1993;643-660.
7. Chen Z., Plagemann P. G. W. Detection of lactate dehydrogenase-elevating virus in transplantable mouse tumors by biological and RT-PCR assays and its removal from the tumor cells. J. Virol. Methods. 65:1997;227-236.
8. Chen Z., Rowland R. R. R., Anderson G. W., Palmer G. A., Plagemann P. G. W. Coexistence in lactate dehydrogenase-elevating virus pools of variants that differ in neuropathogenicity and ability to establish a persistent infection. J. Virol. 71:1997;2913-2920.
9. Chen Z., Li K., Rowland R. R. R., Anderson G. W., Plagemann P. G. W. Lactate dehydrogenase-elevating virus variants: Cosegregation of neuropathogenicity and impaired capability for high viremic persistent infection. J. Neurovirol. 4:1998;560-568.
10. Chen Z., Li K., Plagemann P. G. W. Selective antibody neutralization prevents neuropathogenic lactate dehydrogenase-elevating virus from causing paralytic disease in immunocompetent mice. J. Neurovirol. 5:1999;200-208.
11. Faaberg K. S., Plagemann P. G. W. The envelope proteins of lactate dehydrogenase-elevating virus and their topography in membranes. Virology. 212:1995;512-525.
12. Faaberg K. S., Even C., Palmer G. A., Plagemann P. G. W. Disulfide bonds between two envelope proteins of lactate dehydrogenase-elevating virus are essential for viral infectivity. J. Virol. 69:1995;613-617.
13. Godeny E. K., Chen L., Kumar S. N., Methven S. L., Koonin E. V., Brinton M. A. Complete genomic sequence and phylogenetic analysis of the lactate dehydrogenase-elevating virus (LDV). Virology. 194:1993;585-617.
14. Holland J. J., de la Torre J. C., Steinhauer D. A. RNA virus populations as quasispecies. Curr. Top. Microbiol. Immunol. 176:1992;1-18.
15. Lai M. M. C. RNA recombination in animal and plant viruses. Microbiol. Rev. 56:1992;61-79.
16. Lai M. M. C., Cavanagh D. The molecular biology of coronaviruses. Adv. Virus Res. 48:1997;1-100.
17. Lawrence C. B., Goldman D. A. Definition and identification of homology domains. CABIOS. 4:1988;25-33.
18. Li K., Chen Z., Plagemann P. G. W. The neutralization epitope of lactate dehydrogenase-elevating virus is located on the short ectodomain of the primary envelope glycoprotein. Virology. 242:1998;239-245.
19. Palmer G. A., Kuo L., Chen Z., Faaberg K., Plagemann P. G. W. Sequence of genome of lactate dehydrogenase-elevating virus. Heterogeneity between strains P and C. Virology. 209:1995;637-642.
20. Plagemann P. G. W. Lactate dehydrogenase-elevating virus and related viruses. Virology. 1996;Raven Press, New York. p. 1105-1120.
21. Plagemann, P. G. W. Chen, Z. Li, K. Polylactosaminoglycan chains on the ectodomain of the primary envelope glycoprotein of an arterivirus determine its neuropathogenicity, sensitivity to antibody neutralization and immunogenicity of the neutralization epitope, Curr. Top. Virol.
22. Plagemann P. G. W., Gregory K. F., Swim H. E., Chan K. K. W. Plasma lactic dehydrogenase elevating agent of mice: Distribution in tissues and effect on lactic dehydrogenase isozyme patterns. Can. J. Microbiol. 9:1963;75-86.
23. Plagemann P. G. W., Moennig V. Lactate dehydrogenase-elevating virus, equine arteritis virus and simian hemorrhagic fever virus: A new group of positive-strand RNA viruses. Adv. Virus Res. 41:1992;99-192.
24. Plagemann P. G. W., Rowland R. R. R., Even C., Faaberg K. S. Lactate dehydrogenase-elevating virus - An ideal persistent virus. Semin. Immunopathol. 17:1995;167-186.
25. Zucker M., Stiegler P. Optimal computer folding of large RNA sequences using thermodynamics and auxiliary information. Nucleic Acids Res. 9:1981;133-148.